These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11888667)

  • 1. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
    Ge X; Fu YM; Meadows GG
    Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice.
    Horiuchi H; Kawamata H; Furihata T; Omotehara F; Hori H; Shinagawa Y; Ohkura Y; Tachibana M; Yamazaki T; Ajiki T; Kuroda Y; Fujimori T
    J Exp Clin Cancer Res; 2004 Dec; 23(4):599-606. PubMed ID: 15743030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
    Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
    Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
    Fukazawa H; Uehara Y
    Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
    Brogley MA; Cruz M; Cheung HS
    J Cell Physiol; 1999 Aug; 180(2):215-24. PubMed ID: 10395291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
    Thant AA; Nawa A; Kikkawa F; Ichigotani Y; Zhang Y; Sein TT; Amin AR; Hamaguchi M
    Clin Exp Metastasis; 2000; 18(5):423-8. PubMed ID: 11467775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
    Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
    Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
    Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
    Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor induces the expression of matrix metalloproteinase-3 in human periodontal ligament cells through the MEK2 mitogen-activated protein kinase pathway.
    Shimazu A; Morishita M
    J Periodontal Res; 2003 Apr; 38(2):122-9. PubMed ID: 12608905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
    Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE
    J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
    Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M
    J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
    Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
    Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.